Skip to content
Clinical Trials – home
Verifiedinfo

Unidade Local De Saúde De Santa Maria, E.P.E.

Portugal Avenida Professor Egas Moniz, 1649-035 Lisbon, Portugal

  • 136 trials recruiting
  • Non-small cell lung cancer · Breast cancer · Pulmonary arterial hypertension
  • Adults and children

About Specializations

Unidade Local De Saúde De Santa Maria, E.P.E. in Lisbon, Portugal specialises in clinical trials of conditions such as Non-small cell lung cancer, Breast cancer, Pulmonary arterial hypertension, Sjogren's syndrome, and other specialisations. This site conducts important research.

Main research areas of the site

Nutritional and Metabolic Diseases Research

At Unidade Local De Saúde De Santa Maria, E.P.E., the Pediatria department is involved in clinical research focused on Nutritional and Metabolic Diseases, with a strong emphasis on rare inherited conditions affecting metabolism.

  • Studies centered on Arginase 1 deficiency (ARG1-D), a rare metabolic disorder that can disrupt the body’s ability to process arginine.
  • Research evaluating a new therapy for young children, with attention to how treatment may influence plasma arginine concentrations.
  • Pediatric trials designed to better understand treatment safety and potential clinical benefit in very early childhood.

This area of research at the Lisbon site supports efforts to improve care for children with rare metabolic diseases by testing whether emerging treatments can help manage the underlying biochemical imbalance.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Avenida Professor Egas Moniz1649-035 LisbonPortugal
Recruiting now
136 trials
Conditions studied
197
Partner status
Verified

More sites in LisbonPortugal

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

325 clinical trials

Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:PortugalPortugal
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:PortugalPortugal
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:PortugalPortugal
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:NAVENIBART
  • Sponsor:Astria Therapeutics Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).